Evidence map›Paper›PMID 31592419›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2019

Visualizing the Fate of Intra-Articular Injected Mesenchymal Stem Cells In Vivo in the Second Near-Infrared Window for the Effective Treatment of Supraspinatus Tendon Tears.

Yimeng Yang, Jun Chen, Xiliang Shang, Zhujun Feng, Chen Chen, Jingyi Lu, Jiangyu Cai, Yuzhou Chen, Jian Zhang, Yuefeng Hao and 3 more

Open access · goldAbstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
4.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 39 citations in OpenAlex.

  1. Regenerative biomaterials · 2025
    Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Recent Progress in NIR-II Contrast Agent for Biological Imaging.Frontiers in bioengineering and biotechnology · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Yimeng YangDepartment of Sports Medicine Huashan Hospital Fudan University Shanghai 200040 China.ORCID https://orcid.org/0000-0001-5101-9308
Jun ChenDepartment of Sports Medicine Huashan Hospital Fudan University Shanghai 200040 China.ORCID https://orcid.org/0000-0003-4573-801X
Xiliang ShangDepartment of Sports Medicine Huashan Hospital Fudan University Shanghai 200040 China.
Zhujun FengDepartment of Anatomy and Physiology School of Medicine Shanghai Jiao Tong University Shanghai 200025 China.
Chen ChenDepartment of Sports Medicine Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University Shanghai 200233 China.
Jingyi LuDepartment of Sports Medicine Huashan Hospital Fudan University Shanghai 200040 China.
Jiangyu CaiDepartment of Sports Medicine Huashan Hospital Fudan University Shanghai 200040 China.
Yuzhou ChenDepartment of Sports Medicine Huashan Hospital Fudan University Shanghai 200040 China.
Jian ZhangDepartment of Sports Medicine Huashan Hospital Fudan University Shanghai 200040 China.
Yuefeng HaoDepartment of Orthopedics Affiliated Suzhou Hospital of Nanjing Medical University Suzhou Jiangsu 215500 China.
Xing YangDepartment of Orthopedics Affiliated Suzhou Hospital of Nanjing Medical University Suzhou Jiangsu 215500 China.
Yunxia LiDepartment of Sports Medicine Huashan Hospital Fudan University Shanghai 200040 China.
Shiyi ChenDepartment of Sports Medicine Huashan Hospital Fudan University Shanghai 200040 China.
Fudan University · CNShanghai Jiao Tong University · CNSuzhou Municipal Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mesenchymal stem cells (MSCs) are capable of exerting strong therapeutic potential for the treatment of supraspinatus tendon tear. However, MSC therapy remains underutilized and perhaps underrated due to the limited evidence of dynamic visualization of cellular behavior in vivo. Here, second near-infrared fluorescence imaging with biocompatible PbS quantum dots (QDs) provides a cellular migration map and information on the biodistribution and clearance processes of three densities of intra-articularly injected, labeled MSCs to treat supraspinatus tendon tear in mice. Intra-articular injection avoids entrapment of MSCs by filter organs and reduces the QD-induced organ toxicity. Notably, the MSCs share a similar migration direction, but the moderate density group is somewhat more efficient, showing the longest residence time and highest cell retention rate around the footprint during the repair stage. Furthermore, quantitative kinetic investigation demonstrates that labeled MSCs are cleared by feces and urine. Histomorphometric analysis demonstrates that the moderate density group achieves maximum therapeutic effect and labeled MSCs do not induce any injury or inflammation to major organs, which suggests that administration of too many or few MSCs may decrease their effectiveness. Such an imaging approach provides spatiotemporal evidence for response to MSC therapy in vivo, facilitating the optimization of MSC therapy.

Indexed as

intra‐articular injectionmesenchymal stem cells therapyPbS quantum dotssecond near‐infrared windowsupraspinatus tendon tear

Identifiers

PMID31592419
PMCPMC6774022
OpenAlexW2965480654

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.